ScoutQuest23 Oct 2026
Shukra Pharmaceuticals524632Board meeting scheduled

Board meeting rescheduled to 4 November 2026 to consider Q2 and half-year results

Board meeting rescheduled: the board will now meet on Wednesday, 4 November 2026, revised from the earlier 3 November 2026 date.

By ScoutQuest · · 1 min read

Revised board meeting date
Wednesday, 4 November 2026
Earlier scheduled date
3 November 2026
Results period
second quarter and half year ended 30 September 2026

What the notice says

The company has updated the exchanges on the date of its board meeting. The meeting, earlier scheduled for 3 November 2026, will now be held on Wednesday, 4 November 2026 at the Registered Office of the Company.

What the board will consider

Why the date matters

A board meeting to approve quarterly results is the point at which the company's performance for the quarter becomes public. Investors typically watch for the numbers and the auditor's Limited Review Report that are placed before the board on that date. A one-day shift in the meeting date changes the timing of that disclosure, not the agenda.

Points to note

Source: BSE · 23 Oct 2026

Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.

About ScoutQuest · Logos provided by Logo.dev